LAVA Therapeutics’ License Agreement with Seagen, Inc.

Armstrong Teasdale served as IP counsel to LAVA Therapeutics, while Ballard Spahr served as counsel on additional terms. Seagen Inc. (Nasdaq: SGEN), a world leader and…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now